Physician profile
Wade D Kubat
NPI 1235379256
$7,558.80
in general payments reported to CMS, 2019-2025
14 companies · $2,027 in 2025
The $2,027 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,496 · 2020: $11.99 · 2021: $106 · 2023: $2,434 · 2024: $484 · 2025: $2,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,996 · Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,995.70 |
| Food and Beverage | $1,949.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,415.37 | 2019 | |
| Abbvie INC. | $2,398.63 | 2023-2025 | |
| Axogen | $1,606.15 | 2025 | |
| Mentor Worldwide LLC | $629.78 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 4 Breast Tissue Expander |
| Biocomposites INC | $132.92 | 2019-2025 | Stimulan |
| Integra Lifesciences Corporation | $109.90 | 2021-2024 | Integra, Surgimend, Omnigraft |
| Rti Surgical, INC | $74.17 | 2023-2024 | |
| Kci USA, INC. | $62.03 | 2021 | |
| Allergan, INC. | $24.60 | 2020-2021 | |
| Polynovo North America LLC | $24.58 | 2025 | Novosorb Btm |
| Stryker Corporation | $23.09 | 2024 | Spy-Phi System, Eikon Lt Adapt Smoke Evacuation |
| Davol INC. | $22.98 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $18.96 | 2025 | |
| Sientra, INC. | $15.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Kubat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.